Fortune Brands Innovations, Inc.
FBINFortune Brands Innovations, Inc.'s price has outrun its earnings. −5.6% in a year against EPS −34.1% — the market is paying now for delivery later.
The sharpest disagreement: the price moved −5.6% in a year while annual EPS moved −34.1% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is topping out (6 weeks in) while the P/E sits at the 87th percentile of its own 4-year range. Underneath, the last four quarters read deteriorating — profit −60.0% year on year, and 189% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Fortune Brands Innovations, Inc. trades at $52.7, losing momentum at the top and 6 weeks into that stage. That is +10.7% against its own 200-day average. It sits at 67% of a 52-week range of $34 to $62. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is losing momentum at the top — week 6 of stage 3. At $52.7 it trades +10.7% versus its 200-day average and sits at 67% of its 52-week range ($34–$62).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved −12% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Fortune Brands Innovations, Inc. trades at 23.4× P/E, at the pricey end of its own range (87th percentile). Its long-run median P/E is 17.9×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 23.4× is at the pricey end of its own range (87th percentile), against a long-run median of 17.9× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −34.1% against a −5.6% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the −9.3%/yr price move, ~−14.0%/yr came from earnings growth and ~+4.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Fortune Brands Innovations, Inc. reads as deteriorating on its fundamental arc. Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −2.0% latest against +5.3% at its 12-quarter best), ROCE slipping at 9.0%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −3.3% | −1.9% | — | — |
| Profit | −36.2% | −24.2% | — | — |
| EPS | −34.1% | −22.1% | — | — |
| Stock price | −5.6% | −9.3% | −12.0% | −1.9% |
4-Factor Sector Score
49.6/100 — rank 10 of 29 in Building Products & Equipment · 81% evidence confidence
Fortune Brands Innovations, Inc. scores 49.6 out of 100 against the 29 companies it is compared with in Building Products & Equipment, ranking 10. Price leads the evidence: RS versus the benchmark is -4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 12.7 + 9.8 + 13.6 + 13.5 = 49.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Fortune Brands Innovations, Inc. reported $1.0 B of revenue in the Mar 26 quarter, −1.9% year on year. Over 4 years it has compounded at −1.8% a year. The last full year, FY25, came in at $4.5 B. The last four reported quarters add to $4.4 B.
FY25 revenue came in at $4.5 B (−3.3% on the year), capping 4 years at −1.8% compound. The latest quarter (Mar 26) printed $1.0 B, −1.9% year on year.
Pace check: the last four quarters averaged −2.0% growth against the decade's −1.8% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −2.0% over the last 4 quarters against −2.7%/yr over the last 8 — stabilising; TTM profit −37.2% vs −19.8%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Fortune Brands Innovations, Inc.'s operating margin is 5.9% in the Mar 26 quarter, −3.8 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 11.7% to 16.9%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 5.9%, −3.8 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 11.7%–16.9%.
🚨 Why the margin moved: operating margin went −3.8 pp year on year while gross margin went −0.1 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Fortune Brands Innovations, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −60.0% year on year. Full-year FY25 profit was $0.3 B. The 4-year compound rate is −21.0%. That is 2.0% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Mar 26 profit was $0.0 B, −60.0% year on year. On the full year, FY25 printed $0.3 B (−36.2%), and the 4-year compound rate is −21.0%.
🚨 Why profit moved: revenue contributed −1.9% and the margin −3.8 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −40.1% vs revenue −2.0%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 189% of Fortune Brands Innovations, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.5 B of operating cash against $0.3 B of profit. After $0.1 B of capital spending, $0.4 B was left as free cash.
FY25: operating cash of $0.5 B against reported profit of $0.3 B, leaving free cash of $0.4 B after $0.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 189% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Fortune Brands Innovations, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 7.5% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Fortune Brands Innovations, Inc. earns a ROE of 13% in FY25. Return on invested capital clears the cost of that capital by +0.2 percentage points, so growth here adds value rather than only size. The wiring behind it is 6.7% net margin on 0.68× asset turns.
FY25 ROE is 13%.
Why the return is what it is — the wiring (FY25): 6.7% net margin × 0.68× asset turns × 2.73× balance-sheet leverage ≈ 12.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.2% − 9.0% = a +0.2 pp spread. The 9.0% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Fortune Brands Innovations, Inc. paid $1.01 per share over the last four reported quarters, up 4.0% on a year ago. The most recent declaration was $0.26 for Mar 26. Against the current price of $52.7 that is a trailing yield of 1.92%, measured on dividends already paid rather than on a forecast.
Fortune Brands Innovations, Inc. paid $1.01 per share across the last four reported quarters, most recently $0.26 for Mar 26. That is up 4.0% against the same quarter a year earlier. Against the current price of $52.7 the trailing twelve months work out to 1.92% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Fortune Brands Innovations, Inc. carries total debt of $3.0 B against shareholder equity of $2.4 B as of Mar 26, a debt-to-equity of 1.25. On the annual view that ratio went from 0.92 in FY21 to 1.38 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $3.0 B against shareholder equity of $2.4 B — a debt-to-equity of 1.25. On the annual view, debt-to-equity went from 0.92 (FY21) to 1.38 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
8.5% of Fortune Brands Innovations, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 8.5% of the float is sold short, and at typical trading volumes it would take about 3.4 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Fortune Brands Innovations, Inc.: the Z-score reads 2.78. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.78 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.78.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Masco CorporationMAS | 64.4/100Thin evidence · provisional58% evidence | FADING | 21.6/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence | 17.8/25 ROCE 12.6% · OPM 16.5% 76% evidence | 11.0/20 P/E 18.7× · PEG — 15% evidence | 14.0/20 RS sector 5.3% · RS bench -0.2% · 1Y 11.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 17.8 + 11 + 14 = 64.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Carlisle Companies IncorporatedCSL | 61.8/100Thin evidence · provisional58% evidence | TURNING | 20.1/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 15.6/25 ROCE 6.9% · OPM 17.1% 76% evidence | 10.6/20 P/E 20.8× · PEG — 15% evidence | 15.5/20 RS sector 4.5% · RS bench -0.9% · 1Y 5.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 15.6 + 10.6 + 15.5 = 61.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Apogee Enterprises, Inc.APOG | 59.1/100Mixed-positive evidence71% evidence | TURNING | 20.8/35 Revenue 1.8% · PAT 37.3% · OPM change 3.5 pp 71% evidence | 9.3/25 ROCE 2.1% · OPM 5.5% 76% evidence | 15.8/20 P/E 12× · PEG 0.33 65% evidence | 13.2/20 RS sector 4% · RS bench -1.6% · 1Y 2.4%7 of 12 weeks ahead 70% evidence |
| Exact sum: 20.8 + 9.3 + 15.8 + 13.2 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Trex Company, Inc.TREX | 57.8/100Mixed-positive evidence81% evidence | BREAKING OUT | 18.0/35 Revenue 5.3% · PAT -3.5% · OPM change 0.3 pp 83% evidence | 16.4/25 ROCE 7.6% · OPM 24.3% 76% evidence | 9.2/20 P/E 20.3× · PEG 1.98 65% evidence | 14.2/20 RS sector 2.5% · RS bench -3.8% · 1Y -21.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 16.4 + 9.2 + 14.2 = 57.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Johnson Controls International plcJCI | 57.1/100Thin evidence · provisional58% evidence | TURNING | 18.0/35 Revenue — · PAT — · OPM change -2.1 pp 45% evidence | 13.4/25 ROCE 3.4% · OPM 60.6% 76% evidence | 10.3/20 P/E 25.4× · PEG — 15% evidence | 15.4/20 RS sector 13.9% · RS bench 8.9% · 1Y 45.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 13.4 + 10.3 + 15.4 = 57.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Arlo Technologies, Inc.ARLO | 54.6/100Thin evidence · provisional58% evidence | BASING | 23.2/35 Revenue 10.7% · PAT — · OPM change 6.2 pp 62% evidence | 9.4/25 ROCE 5% · OPM 5% 76% evidence | 9.5/20 P/E 47.8× · PEG — 15% evidence | 12.5/20 RS sector 3.4% · RS bench -2.4% · 1Y -4.7%1 of 12 weeks ahead 70% evidence |
| Exact sum: 23.2 + 9.4 + 9.5 + 12.5 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Griffon CorporationGFF | 54.1/100Mixed-positive evidence81% evidence | FADING | 14.0/35 Revenue -0.8% · PAT -71.7% · OPM change -0.6 pp 83% evidence | 13.5/25 ROCE 4.8% · OPM 20.7% 76% evidence | 12.6/20 P/E 559.1× · PEG 0.54 65% evidence | 14.0/20 RS sector 8.7% · RS bench 3.4% · 1Y 34.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 13.5 + 12.6 + 14 = 54.1 · Decision use: Price leads the evidence: RS versus the benchmark is 3.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Armstrong World Industries, Inc.AWI | 53.5/100Thin evidence · provisional58% evidence | TURNING | 17.7/35 Revenue — · PAT — · OPM change -2.7 pp 45% evidence | 16.6/25 ROCE 8% · OPM 23% 76% evidence | 10.5/20 P/E 22× · PEG — 15% evidence | 8.7/20 RS sector -3.8% · RS bench -9% · 1Y -2.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 16.6 + 10.5 + 8.7 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Trane Technologies plcTT | 51.7/100Thin evidence · provisional58% evidence | BASING | 17.0/35 Revenue — · PAT — · OPM change -1.9 pp 45% evidence | 16.0/25 ROCE 8.2% · OPM 15.6% 76% evidence | 9.7/20 P/E 37.2× · PEG — 15% evidence | 9.0/20 RS sector 2.3% · RS bench -2.6% · 1Y 9.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 16 + 9.7 + 9 = 51.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Fortune Brands Innovations, Inc.this pageFBIN | 49.6/100Mixed-negative evidence81% evidence | BREAKING OUT | 12.7/35 Revenue -2% · PAT -36.5% · OPM change -3.4 pp 83% evidence | 9.8/25 ROCE 1.1% · OPM 6% 76% evidence | 13.6/20 P/E 17× · PEG 0.93 65% evidence | 13.5/20 RS sector 1.6% · RS bench -4.2% · 1Y -5.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 9.8 + 13.6 + 13.5 = 49.6 · Decision use: Price leads the evidence: RS versus the benchmark is -4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11SPX Technologies, Inc.SPXC | 49.3/100Thin evidence · provisional58% evidence | TURNING | 20.5/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 13.4/25 ROCE 3.7% · OPM 15.5% 76% evidence | 9.6/20 P/E 41.6× · PEG — 15% evidence | 5.8/20 RS sector -2.7% · RS bench -7.3% · 1Y 7.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 13.4 + 9.6 + 5.8 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12NPK International Inc.NPKI | 48.3/100Thin evidence · provisional52% evidence | ASLEEP | 18.4/35 Revenue — · PAT — · OPM change -1.7 pp 45% evidence | 12.4/25 ROCE 4.3% · OPM 19.2% 76% evidence | 9.9/20 P/E 31.8× · PEG — 15% evidence | 7.6/20 RS sector -3.3% · RS bench -7.5% · 1Y 46.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.4 + 12.4 + 9.9 + 7.6 = 48.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13AirJoule Technologies CorporationAIRJ | 46.1/100Thin evidence · provisional52% evidence | LEADER | 12.0/35 Revenue — · PAT -249% · OPM change — 57% evidence | 5.7/25 ROCE -1.1% · OPM — 61% evidence | 11.4/20 P/E 8.7× · PEG — 15% evidence | 17.0/20 RS sector 37.7% · RS bench 30% · 1Y 30.4%12 of 12 weeks ahead 70% evidence |
| Exact sum: 12 + 5.7 + 11.4 + 17 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Lennox International Inc.LII | 44.4/100Thin evidence · provisional58% evidence | ASLEEP | 15.3/35 Revenue — · PAT — · OPM change -1.3 pp 45% evidence | 17.7/25 ROCE 13.3% · OPM 14.4% 76% evidence | 10.2/20 P/E 25.9× · PEG — 15% evidence | 1.2/20 RS sector -18% · RS bench -22.3% · 1Y -23.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 17.7 + 10.2 + 1.2 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Owens CorningOC | 44.0/100Mixed-negative evidence64% evidence | BREAKING OUT | 9.1/35 Revenue -5.1% · PAT -308.2% · OPM change -10.8 pp 62% evidence | 7.0/25 ROCE 1.1% · OPM 5.3% 76% evidence | 9.8/20 P/E 35.7× · PEG — 15% evidence | 18.1/20 RS sector 9.4% · RS bench 3.3% · 1Y 1.1%8 of 12 weeks ahead 100% evidence |
| Exact sum: 9.1 + 7 + 9.8 + 18.1 = 44 · Decision use: Price leads the evidence: RS versus the benchmark is 3.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16AAON, Inc.AAON | 43.9/100Mixed-negative evidence81% evidence | ASLEEP | 22.9/35 Revenue 28.2% · PAT -25.8% · OPM change 0.6 pp 83% evidence | 13.4/25 ROCE 4.5% · OPM 11.5% 76% evidence | 4.6/20 P/E 57.9× · PEG 4.21 65% evidence | 3.0/20 RS sector -8.3% · RS bench -12.5% · 1Y 18.7%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 13.4 + 4.6 + 3 = 43.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.3% and the one-year return is 18.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 17Carrier Global CorporationCARR | 43.8/100Thin evidence · provisional58% evidence | ASLEEP | 15.8/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence | 9.8/25 ROCE 2.6% · OPM 4.8% 76% evidence | 9.4/20 P/E 50.9× · PEG — 15% evidence | 8.8/20 RS sector 1.4% · RS bench -3.7% · 1Y -0.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 9.8 + 9.4 + 8.8 = 43.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Quanex Building Products CorporationNX | 43.4/100Mixed-negative evidence69% evidence | BASING | 10.3/35 Revenue 14.3% · PAT -8166.7% · OPM change -5 pp 95% evidence | 6.5/25 ROCE 1% · OPM 4% 76% evidence | 10.1/20 P/E 27.9× · PEG — 15% evidence | 16.5/20 RS sector 14% · RS bench 8.1% · 1Y 6.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.3 + 6.5 + 10.1 + 16.5 = 43.4 · Decision use: Price leads the evidence: RS versus the benchmark is 8.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 19Limbach Holdings, Inc.LMB | 42.3/100Mixed-negative evidence81% evidence | TURNING | 15.5/35 Revenue 22.5% · PAT 0% · OPM change -5.1 pp 83% evidence | 7.3/25 ROCE 0.5% · OPM 0.8% 76% evidence | 12.1/20 P/E 28.4× · PEG 0.94 65% evidence | 7.4/20 RS sector -13.8% · RS bench -18.9% · 1Y -32.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 7.3 + 12.1 + 7.4 = 42.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Aspen Aerogels, Inc.ASPN | 41.1/100Thin evidence · provisional58% evidence | ASLEEP | 20.0/35 Revenue -47.4% · PAT — · OPM change 325.2 pp 62% evidence | 3.0/25 ROCE -5.2% · OPM -55% 76% evidence | 8.9/20 P/E 69.9× · PEG — 15% evidence | 9.2/20 RS sector -0.3% · RS bench -6.8% · 1Y -33%10 of 12 weeks ahead 70% evidence |
| Exact sum: 20 + 3 + 8.9 + 9.2 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Perma-Pipe International Holdings, Inc.PPIH | 39.8/100Mixed-negative evidence79% evidence | BASING | 15.6/35 Revenue 24.4% · PAT 5.9% · OPM change -7.7 pp 95% evidence | 10.7/25 ROCE 3.4% · OPM 9.2% 76% evidence | 8.8/20 P/E 19.3× · PEG 2 65% evidence | 4.7/20 RS sector -16.2% · RS bench -20.3% · 1Y -2.2%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.6 + 10.7 + 8.8 + 4.7 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Janus International Group, Inc.JBI | 38.6/100Thin evidence · provisional58% evidence | TURNING | 13.3/35 Revenue — · PAT — · OPM change -9.9 pp 45% evidence | 8.3/25 ROCE 1.1% · OPM 5.9% 76% evidence | 11.2/20 P/E 15.9× · PEG — 15% evidence | 5.8/20 RS sector -21.4% · RS bench -26.7% · 1Y -42.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 8.3 + 11.2 + 5.8 = 38.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Gibraltar Industries, Inc.ROCK | 36.5/100Mixed-negative evidence75% evidence | TURNING | 12.3/35 Revenue 21.1% · PAT -54.1% · OPM change -12.9 pp 83% evidence | 6.8/25 ROCE -0.3% · OPM -1.3% 76% evidence | 11.7/20 P/E 314× · PEG 0.92 65% evidence | 5.7/20 RS sector -8.4% · RS bench -14% · 1Y -17.4%2 of 12 weeks ahead 70% evidence |
| Exact sum: 12.3 + 6.8 + 11.7 + 5.7 = 36.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24JELD-WEN Holding, Inc.JELD | 35.9/100Thin evidence · provisional58% evidence | 20.1/35 Revenue -12.1% · PAT — · OPM change 16.2 pp 62% evidence | 3.5/25 ROCE -3.3% · OPM -7.6% 76% evidence | 9.3/20 P/E 57.4× · PEG — 15% evidence | 3.0/20 RS sector -58.7% · RS bench -62.8% · 1Y -77.3%4 of 10 weeks ahead 70% evidence | |
| Exact sum: 20.1 + 3.5 + 9.3 + 3 = 35.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Builders FirstSource, Inc.BLDR | 35.5/100Thin evidence · provisional58% evidence | BASING | 14.1/35 Revenue — · PAT — · OPM change -4.5 pp 45% evidence | 8.5/25 ROCE 1.3% · OPM 0.5% 76% evidence | 8.7/20 P/E 98.3× · PEG — 15% evidence | 4.2/20 RS sector -29.7% · RS bench -34.2% · 1Y -43%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 8.5 + 8.7 + 4.2 = 35.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Louisiana-Pacific CorporationLPX | 34.8/100Adverse evidence81% evidence | BASING | 6.0/35 Revenue -13% · PAT -79% · OPM change -10.7 pp 83% evidence | 8.8/25 ROCE 1.5% · OPM 5.9% 76% evidence | 14.0/20 P/E 62.2× · PEG 0.28 65% evidence | 6.0/20 RS sector -11.4% · RS bench -16.3% · 1Y -15.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 6 + 8.8 + 14 + 6 = 34.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 27Latham Group, Inc.SWIM | 33.9/100Adverse evidence64% evidence | BASING | 16.1/35 Revenue 8.7% · PAT — · OPM change -1.2 pp 62% evidence | 4.3/25 ROCE -0.9% · OPM -5.6% 76% evidence | 8.8/20 P/E 75.6× · PEG — 15% evidence | 4.7/20 RS sector -16.6% · RS bench -21.4% · 1Y -22.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 4.3 + 8.8 + 4.7 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Advanced Drainage Systems, Inc.WMS | 33.7/100Adverse evidence81% evidence | TURNING | 12.3/35 Revenue 5% · PAT -5.4% · OPM change -11.1 pp 83% evidence | 10.9/25 ROCE 1.5% · OPM 7.9% 76% evidence | 5.4/20 P/E 25.2× · PEG 4.38 65% evidence | 5.1/20 RS sector -3.7% · RS bench -8.5% · 1Y 14%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.3 + 10.9 + 5.4 + 5.1 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Madison Air Solutions CorporationMAIR | 54.8/100Thin evidence · provisional27% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change -1.4 pp 13% evidence | 15.0/25 ROCE 5.1% · OPM 16.4% 76% evidence | 11.5/20 P/E 0× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 4 weeks ahead 0% evidence |
| Exact sum: 18.3 + 15 + 11.5 + 10 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Fortune Brands Innovations, Inc.'s stock price today?
Fortune Brands Innovations, Inc. trades at $52.7, −5.6% over the past year. The company is valued at $6.0 B. The stock sits at 67% of its 52-week range of $34–$62, +10.7% versus its 200-day average. On the tape, the price is topping out, 6 weeks in. — as of 5 August 2026.
What were Fortune Brands Innovations, Inc.'s latest quarterly results?
Fortune Brands Innovations, Inc. reported revenue of $1.0 B and net profit of $0.0 B for the Mar 26 quarter. Revenue fell 1.9% and profit fell 60.0% year on year. Earnings per share were $0.20. The operating margin was 5.9%, 3.8 pp lower than a year earlier. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s revenue?
Fortune Brands Innovations, Inc. reported revenue of $1.0 B in the Mar 26 quarter, −1.9% year on year. For the full FY25 fiscal year, revenue was $4.5 B (−3.3%). Over the last 4 years revenue compounded at −1.8% a year. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s profit?
Fortune Brands Innovations, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −60.0% year on year. Full-year FY25 profit was $0.3 B. The operating margin ran 5.9% in the latest quarter. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s market cap?
Fortune Brands Innovations, Inc.'s market capitalisation is $6.0 B at a stock price of $52.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s P/E ratio?
Fortune Brands Innovations, Inc. trades at a P/E of 23.4×, at the 87th percentile of its own 4-year range, against a long-run median of 17.9×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Fortune Brands Innovations, Inc. pay a dividend?
Yes — Fortune Brands Innovations, Inc. declared $0.26 per share for Mar 26, and $1.01 per share across the last four reported quarters. The latest quarter is up 4.0% on the same quarter a year earlier. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s dividend per share?
Fortune Brands Innovations, Inc.'s most recently declared dividend is $0.26 per share for Mar 26, giving $1.01 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s dividend yield?
Fortune Brands Innovations, Inc.'s trailing dividend yield is 1.92%: $1.01 declared per share across the last four reported quarters, against a share price of $52.7. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Fortune Brands Innovations, Inc. overvalued?
On its own history, Fortune Brands Innovations, Inc. looks expensive against its own history: its P/E of 23.4× sits at the 87th percentile of its 4-year range (long-run median 17.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is Fortune Brands Innovations, Inc. growing?
Not right now — Fortune Brands Innovations, Inc.'s latest numbers are shrinking: latest-quarter revenue −1.9% year on year, profit −60.0%, and the margin −3.8 pp at 5.9%. The 4-year compound rates are −1.8% (revenue) and −21.0% (profit). The earnings engine currently reads: deteriorating — as of 5 August 2026.
How is Fortune Brands Innovations, Inc. performing?
Fortune Brands Innovations, Inc. is topping out, 6 weeks in. Its latest quarter's revenue fell 1.9% and profit fell 60.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Fortune Brands Innovations, Inc. in?
Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −2.0% latest against +5.3% at its 12-quarter best), ROCE slipping at 9.0%. The read comes from the last 12 quarters of growth (revenue growth −2.0% latest, profit growth −37.2% latest, eps growth −34.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Fortune Brands Innovations, Inc. in an uptrend?
It is stalling — the price is topping out (week 6 of stage 3), trading +10.7% versus its 200-day average and at 67% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Fortune Brands Innovations, Inc. beating the market?
On recent form, yes — Fortune Brands Innovations, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved −12% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Fortune Brands Innovations, Inc.'s stock price go up?
This page publishes no price forecast for Fortune Brands Innovations, Inc. What it measures instead: the stock price is $52.7, the price is topping out 6 weeks in. Its P/E of 23.4× sits at the 87th percentile of its own 4-year range. — as of 5 August 2026.
Is the market betting against Fortune Brands Innovations, Inc.?
Somewhat — short interest is 8.5% of Fortune Brands Innovations, Inc.'s tradable float, about 3.4 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Fortune Brands Innovations, Inc. have too much debt?
It carries real leverage — Fortune Brands Innovations, Inc.'s debt-to-equity is 1.26. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s capex?
Fortune Brands Innovations, Inc. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 5 August 2026.
What is Fortune Brands Innovations, Inc.'s cash flow?
Fortune Brands Innovations, Inc. generated $0.5 B of operating cash flow in FY25 and $0.4 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $0.3 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Fortune Brands Innovations, Inc.'s profit real cash?
Yes — over the last 3 fiscal years, 189% of Fortune Brands Innovations, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.5 B against reported profit of $0.3 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Fortune Brands Innovations, Inc.?
On the balance sheet, the Z-score reads 2.78 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is Fortune Brands Innovations, Inc. in its business cycle?
Fortune Brands Innovations, Inc.'s FY25 operating margin was 11.7%, against a 5-year band of 11.7%–16.9%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 5.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Fortune Brands Innovations, Inc. story?
The sharpest disagreement: the price moved −5.6% in a year while annual EPS moved −34.1% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Fortune Brands Innovations, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Fortune Brands Innovations, Inc.'s price has outrun its earnings. −5.6% in a year against EPS −34.1% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.